My compounded semaglutide provider shut down. Where should I move my treatment?

Sorry that happened — that’s stressful. You have safe, reliable options for continuing treatment; the key is switching to an FDA‑approved product and a licensed prescriber rather than another unnamed compounder.

Recommendations and why

1. Switch to an FDA‑approved semaglutide product

• Wegovy (Novo Nordisk) — approved specifically for chronic weight management (preferred for prescribing weight loss).
• Ozempic (Novo Nordisk) — approved for type 2 diabetes; sometimes used by prescribers for weight loss but Wegovy is the labeled weight‑loss product.
• Rybelsus (Novo Nordisk) — oral semaglutide if you prefer a pill rather than injections. Why: FDA manufacturing standards, known dosing, safety monitoring, manufacturer patient support programs.

1. See a licensed prescriber to restart therapy

• Primary care doctor, endocrinologist, or an obesity medicine specialist (search the American Board of Obesity Medicine (ABOM) directory for board‑certified providers). Why: They’ll convert your old compounded dose to the correct FDA product and schedule, handle monitoring, and arrange insurance/prior authorization if needed.

1. Reputable telehealth options (if you can’t get a local provider quickly)

• One Medical — primary‑care + in‑person option in many cities.
• Ro (Roman)/Ro Weight Loss program and Hims & Hers — offer telehealth evaluations and prescriptions for GLP‑1s in many states.
• PlushCare and GoodRx Care — also commonly prescribe GLP‑1 therapy via telehealth. Why: Faster access to a licensed clinician and convenient follow‑up; still use major pharmacies and ask about safety monitoring.

1. Where to fill prescriptions

• Large retail chains and specialty pharmacies: CVS, Walgreens, Walmart, and specialty pharmacies (some injectables route through specialty pharmacies like Accredo).
• Contact the manufacturer (Novo Nordisk) patient support for Wegovy/Ozempic for savings programs and help with coverage. Why: Reliable supply, guaranteed product quality, manufacturer support for injections and insurance help.

Other options to discuss with your clinician

• Tirzepatide products (Mounjaro for diabetes, Zepbound for weight management by Eli Lilly) — different drug class (GIP/GLP‑1) that many people and clinicians consider because of strong weight‑loss results. Discuss risks/benefits with your provider.

Important practical steps right now

• Bring or send your new provider any records you have from the compounding pharmacy (dose, concentration, start date, response, side effects).
• Don’t try to convert doses yourself — compounded concentrations may differ from commercial pens; let the prescriber make the conversion.
• Ask about monitoring (gastrointestinal side effects, pancreatitis risk, thyroid history, gallbladder issues) and insurance/prior‑auth assistance.
• Avoid unknown online pharmacies or foreign compounders — use licensed U.S. pharmacies and a licensed prescriber.

If you want, tell me: what product and dose you were using from the compounder and whether you have an in‑network primary care or prefer telehealth, and I’ll suggest the best next step (which drug to ask for or draft a message you can send to a new prescriber).